Taysha Gene Therapies, Inc. (TSHA) ownership: Top institutional holder: RA CAPITAL MANAGEMENT, L.P. ($105.29M). Insider activity: Net Seller (0 buys, 4 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 23555648.00 | $105.29M | 2026-03-31 |
| GOLDMAN SACHS GROUP INC | 22369645.00 | $99.99M | 2026-03-31 |
| Avoro Capital Advisors LLC | 21700000.00 | $97.00M | 2026-03-31 |
| BlackRock, Inc. | 18365608.00 | $82.09M | 2026-03-31 |
| Vestal Point Capital, LP | 18000000.00 | $80.46M | 2026-03-31 |
| MORGAN STANLEY | 17965371.00 | $80.31M | 2026-03-31 |
| VANGUARD GROUP INC | 13267805.00 | $72.97M | 2025-12-31 |
| FMR LLC | 14321255.00 | $64.02M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-04-10 | |
| Sell | null | 2026-04-10 | |
| Sell | null | 2026-04-10 | |
| Sell | null | 2026-02-04 |
Back to TSHA overview · TSHA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.